Search
for
Sort by
Research 811–840 of 1000+
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- A REVIEW ON COLOURFUL MEHENDI: THE RISK OF PARAPHENYLENEDIAMINE
- Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis
- Male pattern baldness and the risk of prostate cancer
- Endocrine disruptors as risk factors for idiopathic premature thelarche in girls: A case-control study
- 643 Male pattern baldness and risk of incident skin cancer in a cohort of men
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Follow-up of Nutritional and Metabolic Problems After Bariatric Surgery
- Genome-wide meta-analysis identifies novel loci conferring risk of acne vulgaris
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans
- Is Prenatal Sex Hormone Balance a Risk Factor for the Development of Hidradenitis Suppurativa
- DNA Methylation‐Regulated ZDHHC17 Promotes the Risk of Facial Skin Aging
- Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece
- Research on the Mechanism of Hair Dyeing Agents and Strategies for Health Risks Reduction
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Synergistic Effects of Cinnamomum zeylanicum and Inositol on Metabolic and Hormonal Parameters in Women with Polycystic Ovary Syndrome
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
- Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population
- Central hair loss in African American women: Incidence and potential risk factors